Molecular Formula | C33H34N4O6 |
Molar Mass | 582.65 |
Density | 1.33±0.1 g/cm3(Predicted) |
Melting Point | 120-126°C |
Boling Point | 709.3±60.0 °C(Predicted) |
Flash Point | 382.8°C |
Solubility | DMSO: >10mg/mL |
Vapor Presure | 5.74E-20mmHg at 25°C |
Appearance | powder |
Color | Yellow |
Merck | 14,907 |
pKa | 7.89(at 25℃) |
Storage Condition | Keep in dark place,Inert atmosphere,Room temperature |
Refractive Index | 1.658 |
MDL | MFCD00865803 |
Use | Azelnidipine is a dihydropyridine calcium channel blocker. |
In vitro study | Azelnidipine is a newly developed long-acting calcium channel blocker with unique pharmacological properties, such as slowing the heartbeat and high affinity for vascular tissue, these properties make it different from other calcium channel blockers, so Azelnidipine is a new generation of calcium channel blockers that can be used to treat high blood pressure, regardless of whether the patient is at risk of ischemic heart disease. Because of its high fat solubility, it can still remain in the blood vessel wall after it is cleared from the blood. |
Hazard Symbols | Xn - Harmful |
Risk Codes | R22 - Harmful if swallowed R41 - Risk of serious damage to eyes |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S39 - Wear eye / face protection. |
WGK Germany | 3 |
RTECS | US7968332 |
Toxicity | LD50 in female, male mice, female, male rats (mg/kg): 785, 979, 1267, 1971 orally |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 1.716 ml | 8.581 ml | 17.163 ml |
5 mM | 0.343 ml | 1.716 ml | 3.433 ml |
10 mM | 0.172 ml | 0.858 ml | 1.716 ml |
5 mM | 0.034 ml | 0.172 ml | 0.343 ml |